Earnings Call · Q4 FY2024·2025-02-27

Q4 24EPS -7.33%·Rev n/aQ3 24EPS -9.68%·Rev n/aQ2 24EPS -43.96%·Rev n/aQ1 24EPS -13.68%·Rev n/a⚠ consensus missing

CYTOKINETICS INC CYTK

Diane Weiser — Investor Relations

Robert Blum — President and Chief Executive Officer

Andrew Callos — Executive Vice President and Chief Commercial Officer

Fady Malik — Executive Vice President, Chief Medical Officer

Isaac Ciechanover — Executive Vice President, Corporate Development

Stuart Kupfer — Senior Vice President, Clinical Development

Sung Lee — Executive Vice President and Chief Financial Officer

−3.1%1d on move date−4.6% vs SPY3d−7.9%5d−8.8%

Research tier

Behavioral profile computed for 7 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more CYTK calls or request research access.

More CYTK calls Browse calls Request research access